Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats

References

• Cuervo AM. Chaperone-mediated autophagy: Dice's ‘wild’ idea about lysosomal selectivity. Nat Rev Mol Cell Biol 2011; 12:535-41; PMID:21750569; http://dx.doi.org/10.1038/nrm3150
   PubMed Web of Science ®Google Scholar
• Dice JF. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990; 15:305-9; PMID:2204156; http://dx.doi.org/10.1016/0968-0004(90)90019-8
   PubMed Web of Science ®Google Scholar
• Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kgdalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989; 246:382-5; PMID:2799391; http://dx.doi.org/10.1126/science.2799391
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996; 273:501-3; PMID:8662539; http://dx.doi.org/10.1126/science.273.5274.501
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008; 28:5747-63; PMID:18644871; http://dx.doi.org/10.1128/MCB.02070-07
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Knecht E, Terlecky SR, Dice JF. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol 1995; 269:C1200-8; PMID:7491910
   PubMed Web of Science ®Google Scholar
• Hubbi ME, Hu H, Kshitiz Ahmed I, Levchenko A, Semenza GL. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J Biol Chem 2013; 288:10703-14; PMID:23457305; http://dx.doi.org/10.1074/jbc.M112.414771
   PubMed Web of Science ®Google Scholar
• Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004; 15:4829-40; PMID:15331765; http://dx.doi.org/10.1091/mbc.E04-06-0477
   PubMed Web of Science ®Google Scholar
• Koga H, Martinez-Vicente M, Arias E, Kaushik S, Sulzer D, Cuervo AM. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. J Neurosci 2011; 31:18492-505; PMID:22171050; http://dx.doi.org/10.1523/JNEUROSCI.3219-11.2011
   PubMed Web of Science ®Google Scholar
• Park C, Suh Y, Cuervo AM. Regulated degradation of Chk1 by chaperone-mediated autophagy in response to DNA damage. Nat Commun 2015; 6:6823; PMID:25880015; http://dx.doi.org/10.1038/ncomms7823
   PubMed Web of Science ®Google Scholar
• Eskelinen EL, Cuervo AM, Taylor MR, Nishino I, Blum JS, Dice JF, Sandoval IV, Lippincott-Schwartz J, August JT, Saftig P. Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2. Traffic 2005; 6:1058-61; PMID:16190986; http://dx.doi.org/10.1111/j.1600-0854.2005.00337.x
   PubMed Web of Science ®Google Scholar
• Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci U S A 2006; 103:5805-10; PMID:16585521; http://dx.doi.org/10.1073/pnas.0507436103
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF. Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci 2000; 113 Pt 24:4441-50; PMID:11082038
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem 2000; 275:31505-13; PMID:10806201; http://dx.doi.org/10.1074/jbc.M002102200
   PubMed Web of Science ®Google Scholar
• Zhang C, Cuervo AM. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med 2008; 14:959-65; PMID:18690243; http://dx.doi.org/10.1038/nm.1851
   PubMed Web of Science ®Google Scholar
• Schneider JL, Suh Y, Cuervo AM. Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation. Cell Metab 2014; 20:417-32; PMID:25043815; http://dx.doi.org/10.1016/j.cmet.2014.06.009
   PubMed Web of Science ®Google Scholar
• Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008; 283:23542-56; PMID:18566453; http://dx.doi.org/10.1074/jbc.M801992200
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292-5; PMID:15333840; http://dx.doi.org/10.1126/science.1101738
   PubMed Web of Science ®Google Scholar
• Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 2013; 14:38-48; PMID:23254192; http://dx.doi.org/10.1038/nrn3406
   PubMed Web of Science ®Google Scholar
• Vekrellis K, Stefanis L. Targeting intracellular and extracellular α-synuclein as a therapeutic strategy in Parkinson disease and other synucleinopathies. Exp Opin Therapeutic Targets 2012; 16:421-32; PMID:22480256; http://dx.doi.org/10.1517/14728222.2012.674111
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 2010; 67:1464-72; PMID:20697033; http://dx.doi.org/10.1001/archneurol.2010.198
   PubMed Web of Science ®Google Scholar
• Murphy KE, Gysbers AM, Abbott SK, Spiro AS, Furuta A, Cooper A, Garner B, Kabuta T, Halliday GM. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson disease. Mov Disord 2015; 30(12):1639-47; PMID:25594542
   PubMed Web of Science ®Google Scholar
• Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson disease. Brain 2014; 137:834-48; PMID:24477431; http://dx.doi.org/10.1093/brain/awt367
   PubMed Web of Science ®Google Scholar
• Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson disease: evidence from studies of non-human primates. Nat Rev Neurosci 2011; 12:359-66; PMID:21587290; http://dx.doi.org/10.1038/nrn3039
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Landeck N, Pitychoutis PM, Papasilekas T, Papadopoulou-Daifoti Z, Kirik D, Stefanis L. Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration. Brain 2013; 136:2130-46; PMID:23757764; http://dx.doi.org/10.1093/brain/awt131
   PubMed Web of Science ®Google Scholar
• Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. Lysosomal degradation of α-synuclein in vivo. J Biol Chem 2010; 285:13621-9; PMID:20200163; http://dx.doi.org/10.1074/jbc.M109.074617
   PubMed Web of Science ®Google Scholar
• Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002; 52:205-10; PMID:12210791; http://dx.doi.org/10.1002/ana.10279
   PubMed Web of Science ®Google Scholar
• Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L. Abberant α-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PloS One 2009; 4:e5515; PMID:19436756; http://dx.doi.org/10.1371/journal.pone.0005515
   PubMed Web of Science ®Google Scholar
• Burke RE, O'Malley K. Axon degeneration in Parkinson disease. Exp Neurol 2013; 246:72-83; PMID:22285449; http://dx.doi.org/10.1016/j.expneurol.2012.01.011
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Schapira AH, Rodriguez-Oroz MC, Obeso JA, Cooper JM. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson disease. Cell Death Dis 2013; 4:e545; PMID:23492776; http://dx.doi.org/10.1038/cddis.2013.73
   PubMed Web of Science ®Google Scholar
• Rothaug M, Stroobants S, Schweizer M, Peters J, Zunke F, Allerding M, D'Hooge R, Saftig P, Blanz J. LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease. Acta Neuropathologica Commun 2015; 3:6; PMID:25637286; http://dx.doi.org/10.1186/s40478-014-0182-y
   PubMed Web of Science ®Google Scholar
• Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, Tanaka Y, Lullmann-Rauch R, Hartmann D, Heeren J, et al. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 2004; 15:3132-45; PMID:15121881; http://dx.doi.org/10.1091/mbc.E04-02-0103
   PubMed Web of Science ®Google Scholar
• Ahmed I, Liang Y, Schools S, Dawson VL, Dawson TM, Savitt JM. Development and characterization of a new Parkinson disease model resulting from impaired autophagy. J Neurosci 2012; 32:16503-9; PMID:23152632; http://dx.doi.org/10.1523/JNEUROSCI.0209-12.2012
   PubMed Web of Science ®Google Scholar
• Friedman LG, Lachenmayer ML, Wang J, He L, Poulose SM, Komatsu M, Holstein GR, Yue Z. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. J Neurosci 2012; 32:7585-93; PMID:22649237; http://dx.doi.org/10.1523/JNEUROSCI.5809-11.2012
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406:902-6; PMID:10972293; http://dx.doi.org/10.1038/35022595
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C, eds. The Rat Brain in Stereotaxic Coordinates. Academic Press, 1998.
   Google Scholar
• Storrie B, Madden EA. Isolation of subcellular organelles. Meth Enzymol 1990; 182:203-25; PMID:2156127; http://dx.doi.org/10.1016/0076-6879(90)82018-W
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Dice JF, Knecht E. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 1997; 272:5606-15; PMID:9038169; http://dx.doi.org/10.1074/jbc.272.9.5606
   PubMed Web of Science ®Google Scholar
• Xilouri M, Brekk OR, Kirik D, Stefanis L. LAMP2A as a therapeutic target in Parkinson disease. Autophagy 2013; 9:2166-8; PMID:24145820; http://dx.doi.org/10.4161/auto.26451
   PubMed Web of Science ®Google Scholar
• Moss J, Bolam JP. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 2008; 28:11221-30; PMID:18971464; http://dx.doi.org/10.1523/JNEUROSCI.2780-08.2008
   PubMed Web of Science ®Google Scholar
• Miner LH, Jedema HP, Moore FW, Blakely RD, Grace AA, Sesack SR. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci 2006; 26:1571-8; PMID:16452680; http://dx.doi.org/10.1523/JNEUROSCI.4450-05.2006
   PubMed Web of Science ®Google Scholar
• Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx 2006; 3:497-504; PMID:17012064; http://dx.doi.org/10.1016/j.nurx.2006.08.001
   PubMedGoogle Scholar